Dopamine receptor D2 intronic polymorphism in patients with Parkinson's disease

Neuroscience Letters

Volumn 273, Issue 3, 1999, Pages 151-154

  Pastor, Pau ^a   Muñoz, Esteban ^a   Obach, Victor ^a   Martí, María José ^a   Blesa, Rafael ^a   Oliva, Rafael ^a   Tolosa, Eduardo ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Dopamine receptor D2; Genetics; Parkinson's disease; Spanish

Indexed keywords

DOPAMINE 2 RECEPTOR; REPETITIVE DNA;

ADULT; AGED; ALLELE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT; SHORT SURVEY; SPAIN;

EID: 0344931853     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00633-3     Document Type: Article

References (22)

1. Amstrong M., Daly A.K., Cholerton S., Bateman D.N., Idle J.R. Mutant debrisoquine hydroxylase genes in Parkinson's disease. Lancet. 339:1992;1017-1018.
2. Bandmann O., Davis M.B., Marsden C.D., Harding A.E. Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 59:1995;90-91.
3. Bandmann O., Marsden C.D., Wood N.W. Genetic aspects of Parkinson's disease. Movement Disorders. 13:1998;203-211.
4. Comings D.E., Comings B.G., Muhleman D., Dietz G., Shahbahrami B., Tast D., Knell C., Kocsis P., Baumgarten R., Kovacs B.W., Levy D.L., Smith M., Borison R.L., Evans D., Klein L.M., MacMurray J., Tosk J.M., Sverd G., Gysin R., Flanagan S.D. The dopamine D2 receptor locus as a modifying gene in neuropsychiatry disorders. J. Am. Med. Assoc. 266:1991;1793-1800.
5. Gasser T., Wszolek Z.K., Trofatter J., Ozelius B.S., Uitti R.J., Lee C.S., Gusella J., Pfeiffer R.F., Calne D.B., Breakefield X.O. Genetic linkage studies in autosomal dominant parkinsonism: evaluation on seven candidate genes. Ann. Neurol. 36:1994;387-396.
6. Gibb W.R.G., Lees A.J. The relevance of Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 51:1988;745-752.
7. Grandy D.K., Litt M., Aleen L., Bunzow J.R., Marchionni M., Makam H., Reed L., Magenis R.E., Civelli O. The human dopamine receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RPLF. Am. J. Hum. Genet. 45:1989;778-785.
8. Guttman M. Dopamine receptors in Parkinson's disease. Neurol. Clin. 10:1992;377-386.
9. Hauge X.Y., Grandy D.K., Eubanks J.H., Evans G.A., Civelli O., Litt M. Detection and characterisation of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics. 10:1991;527-530.
10. Higuchi S., Muramatsu T., Arai H., Hayashida M., Sasaki H., Trojanowski J.Q. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. J. Neural. Transm. 10:1995;107-113.
11. Kitada T., Asakava S., Hattori T., Matsumine H., Yamamura Y., Minoshima S., Yokichi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:(9):1998;544-547.
12. Kurth J.H., Kurth M.C., Poduslo S.E., Schwankhaus J.D. Association of monoamine oxidase B allele with Parkinson's disease. Ann. Neurol. 33:1993;368-372.
13. Lucotte G., Turpin J.C., Gerard N., Panserat S., Krishnamoorthy R. Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families. Am. J. Med. Genet. 67:1996;361-365.
14. Marder K., Tang M.X., Mejia H., Alfaro B.A., Coté, L., Louis E., Groves J., Mayeux R. Risk of Parkinson's disease among first degree relatives: a community-based study. Neurology. 47:1996;155-160.
15. Muñ̃oz E., Obach V., Oliva R., Martí M.J., Ezquerra M., Pastor P., Ballesta F., Tolosa E E. α1-Antichymotrypsin gene polymorphism and susceptibility to Parkinson's disease. Neurology. 52:1999;297-301.
16. Nanko S., Ueki A., Hattori M., Dai X.Y., Sasaki T., Fukuda R., Ikeda K., Kazamatsuri H. No allelic association between Parkinson's disease and dopamine D2, D3 and D4 receptor gene polymorphisms. Am. J. Med. Genet. 54:1994;361-364.
17. Parboosingh J.S., Rousseau M., Rogan F., Amit Z., Chertkow H., Johnson W.G., Manganaro F., Schipper H.N., Curran T.J., Stoessl J., Rouleau G.A. Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease. Arch. Neurol. 52:1995;1160-1163.
18. Plante-Bordeneuve V., Davis M.B., Maraganore D.M., Marsden C.D., Harding A.E. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 57:1994;911-913.
19. Planté -Bordeneuve V., Taussig D., Thomas F., Said G., Wood N.W., Marsden C.D., Harding A.E. Evaluation or four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence of association of a DRD2 allele 48. Neurology. 48:1997;1589-1593.
20. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubestein J., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
21. Ricketts M.H., Hamer R.M., Manowitz P., Feng F., Sage J.I., Di Paola R., Menza M.A. Association of long variants of the dopamine D4 receptor exon 3 repeat polymorphism with Parkinson's disease. Clin. Genet. 54:1998;33.
22. Yamamoto M., Kondo I., Ogawa N., Anasuma M., Yamashita Y., Mizuno Y. Genetic association between susceptibility to Parkinson's disease and α1-antichymotrypsin polymorphism. Brain Res. 759:1997;153-155.